These molecular markers, particularly TET2/IDH (OR 1.87, 95% CI [1.08; 3.2], p = 0.02) and SRSF2 (OR 2.21, 95% CI [1.14; 4.28], p = 0.02), underscore the unique genetic landscape of SIAD MDS and may contribute to their distinct clinical presentation and prognosis [27]. The gene discussed is IDH2; the disease is myelodysplastic syndrome.